K Browne

997 total citations
19 papers, 479 citations indexed

About

K Browne is a scholar working on Pulmonary and Respiratory Medicine, Health, Toxicology and Mutagenesis and Public Health, Environmental and Occupational Health. According to data from OpenAlex, K Browne has authored 19 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 4 papers in Health, Toxicology and Mutagenesis and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in K Browne's work include Occupational and environmental lung diseases (10 papers), Air Quality and Health Impacts (4 papers) and Pleural and Pulmonary Diseases (4 papers). K Browne is often cited by papers focused on Occupational and environmental lung diseases (10 papers), Air Quality and Health Impacts (4 papers) and Pleural and Pulmonary Diseases (4 papers). K Browne collaborates with scholars based in United Kingdom, United States and Ireland. K Browne's co-authors include Deborah Yates, B Corrin, E.B. Ilgren, J. Bernard L. Gee, Jeffrey L. Anderson, H W Eckerson, Sherman G. Sorensen, Vincent Dangoisse, Rosemary A. Hackworthy and Fidela Moreno and has published in prestigious journals such as Circulation, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

K Browne

18 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Browne United Kingdom 9 394 88 80 79 69 19 479
Madelaine Plourde Canada 9 128 0.3× 32 0.4× 47 0.6× 18 0.2× 19 0.3× 18 190
Hakan M. Poyrazoğlu Türkiye 9 140 0.4× 13 0.1× 48 0.6× 6 0.1× 8 0.1× 15 242
Brian Blew Canada 10 238 0.6× 21 0.2× 82 1.0× 46 0.6× 2 0.0× 26 304
Mina Fam United States 10 83 0.2× 25 0.3× 152 1.9× 23 0.3× 5 0.1× 24 263
G. Kooiman United Kingdom 7 113 0.3× 14 0.2× 197 2.5× 14 0.2× 10 0.1× 15 382
Guoying Huang China 9 147 0.4× 10 0.1× 106 1.3× 53 0.7× 10 0.1× 37 393
Paolo Vincenzi Italy 10 64 0.2× 15 0.2× 168 2.1× 12 0.2× 10 0.1× 32 251
Federico Mei Italy 10 245 0.6× 9 0.1× 56 0.7× 21 0.3× 4 0.1× 37 321
Mike McNamara United States 6 217 0.6× 15 0.2× 198 2.5× 7 0.1× 4 0.1× 6 308
Fion Siu‐Yin Chan Hong Kong 11 124 0.3× 9 0.1× 180 2.3× 10 0.1× 24 0.3× 33 285

Countries citing papers authored by K Browne

Since Specialization
Citations

This map shows the geographic impact of K Browne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Browne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Browne more than expected).

Fields of papers citing papers by K Browne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Browne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Browne. The network helps show where K Browne may publish in the future.

Co-authorship network of co-authors of K Browne

This figure shows the co-authorship network connecting the top 25 collaborators of K Browne. A scholar is included among the top collaborators of K Browne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Browne. K Browne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Browne, K, Ewa Bałkowiec-Iskra, André Elferink, et al.. (2025). Applying the EU Regulatory Framework to Determine the Benefit–Risk Profile of Psychedelics. ACS Pharmacology & Translational Science. 8(8). 2830–2838.
2.
McCormick, P. Aiden, Paul Holder, Cillian De Gascun, et al.. (2025). Community prevalence of blood-borne viruses (hepatitis B and HIV) in Ireland. Irish Journal of Medical Science (1971 -). 194(2). 491–495. 1 indexed citations
3.
Browne, K, Daniel R. Morales, Charlotte Warren‐Gash, et al.. (2025). Association Between β‐Adrenoreceptor Agonists and Antagonists and Parkinson's Disease: Systematic Review and Meta‐Analysis. Pharmacoepidemiology and Drug Safety. 34(4). e70140–e70140. 1 indexed citations
4.
McCormick, P. Aiden, Cillian De Gascun, John S. Lambert, et al.. (2024). Hepatitis C community prevalence is over-estimated: a prospective, birth cohort study. Irish Journal of Medical Science (1971 -). 193(3). 1257–1260. 1 indexed citations
5.
Browne, K, et al.. (2021). An exploration of the impact of ethanol diluent on breath alcohol concentration in patients receiving paclitaxel chemotherapy. Cancer Chemotherapy and Pharmacology. 88(2). 307–312. 1 indexed citations
6.
Browne, K, et al.. (2010). Clinical observed performance evaluation: a prospective study in final year students of surgery. Advances in Health Sciences Education. 16(1). 47–57. 3 indexed citations
7.
Browne, K & J. Bernard L. Gee. (2000). Asbestos exposure and laryngeal cancer. The Annals of Occupational Hygiene. 44(4). 239–50. 16 indexed citations
9.
Yates, Deborah, et al.. (1996). Asbestos-Related Bilateral Diffuse Pleural Thickening: Natural History of Radiographic and Lung Function Abnormalities. American Journal of Respiratory and Critical Care Medicine. 153(1). 301–306. 41 indexed citations
10.
Whitaker, D., et al.. (1996). Mesothelioma in a community in the north of England.. Occupational and Environmental Medicine. 53(8). 547–552. 11 indexed citations
11.
Shapiro, Daniel S., et al.. (1996). Peripartum Bacteremia with CDC Group HB-5 (Pasteurella bettyae). Clinical Infectious Diseases. 22(6). 1125–1126. 6 indexed citations
12.
Addison, J., K Browne, J. Michael Davis, & Ulrich F. Gruber. (1993). Asbestos Fibers in Parenteral Medication. Regulatory Toxicology and Pharmacology. 18(3). 371–380. 2 indexed citations
13.
Ilgren, E.B. & K Browne. (1991). Asbestos-related mesothelioma: Evidence for a threshold in animals and humans. Regulatory Toxicology and Pharmacology. 13(2). 116–132. 25 indexed citations
14.
Anderson, Jeffrey L., Sherman G. Sorensen, Fidela Moreno, et al.. (1991). Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study Investigators.. Circulation. 83(1). 126–140. 59 indexed citations
15.
Venables, K M, Aidan Davison, K Browne, & Anthony J. Taylor. (1989). Pseudo-occupational asthma.. Thorax. 44(9). 760–761. 4 indexed citations
16.
Browne, K. (1986). Is asbestos or asbestosis the cause of the increased risk of lung cancer in asbestos workers?. Occupational and Environmental Medicine. 43(3). 145–149. 52 indexed citations
17.
Browne, K. (1986). A threshold for asbestos related lung cancer.. Occupational and Environmental Medicine. 43(8). 556–558. 31 indexed citations
18.
Browne, K, et al.. (1983). Asbestos-related mesothelioma: factors discriminating between pleural and peritoneal sites.. Occupational and Environmental Medicine. 40(2). 145–152. 66 indexed citations
19.
Browne, K, et al.. (1982). Criteria for the diagnosis of asbestosis and considerations in the attribution of lung cancer and mesothelioma to asbestos exposure. International Archives of Occupational and Environmental Health. 49(3-4). 357–361. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026